Sanofi's venglustat accepted for priority review in the US to treat type 3 Gaucher disease Paris, May 28, 2026. The US Food and Drug Administration (FDA) has granted priority review to the new drug ...

FDA approved AVLAYAH™ (tividenofusp alfa-eknm) for treatment of Hunter syndrome (MPS II) and as first medicine to leverage transferrin receptor ...

MDS-UPDRS scores remained stable and durable across overall study population after 150 days of treatment with ...

The US Food and Drug Administration (FDA) has granted priority review to the new drug application (NDA) for Sanofi’s (Euronext: SAN) venglustat, a novel, investigational oral glucosylceramide synthase ...

The Australian life sciences sector is emerging from its “time in the desert” since the 2023 post-pandemic slump, according ...

Kyle Busch’s family says the NASCAR superstar died after severe pneumonia progressed into sepsis, a dangerous condition that ...

The Southern Nevada Health District released a statement on Tuesday, April 28, that it "is investigating two travel-associated cases of Legionnaires’ disease associated with stays at the Wynn Las ...

Keaton Herzer tells PEOPLE a newer targeted therapy unexpectedly shrank his tumors enough to qualify for a liver transplant ...

Samples collected by officials at the Wynn Las Vegastested positive for Legionella, the bacteria that can cause Legionnaires' disease Christopher Edwards is a writer on the Lifestyle team at PEOPLE.

People with a rare genetic disorder that damages the amygdala are helping neuroscientists rethink how the brain shapes fear, ...

May is ALS Awareness Month, and a Chicago couple is tackling the devastating disease head-on.

Lucia Adarve had a long list of symptoms that no one could diagnose. Her mother Lisa was determined to find an answer.